Otros idiomas Anteris Technologies Ltd

Acciones

AVR

AU0000088841

Mercado cerrado - Australian S.E. Otros sitios de cotización 08:10:44 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
22,75 ^AUD	-1,09 %		-1,09 %	+18,80 %

10/04	Anteris Technologies recauda 23 millones de dólares australianos para el estudio DurAVR	MT
13/03	Anteris declara resultados optimistas de los ensayos en humanos de su válvula cardiaca	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Anteris Technologies Posts AU$10.6 Million Cash, AU$20.2 Million Net Cash Outflows for Quarter Ended March 31	18/04
Anteris Technologies Raises AU$23 Million for DurAVR Study	10/04
Anteris Declares Upbeat Results from Human Trials of Heart Valve	13/03
Anteris Technologies Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Anteris talks market superiority of its biomimetic TAVR valve	31/10/23
Anteris Technologies Completes Enrollment for Heart Valve Device Study	17/10/23
Anteris Technologies Secures AU$1 Million Tax Rebate for 2022	13/10/23
Anteris Technologies Ltd(ASX:AVR) dropped from S&P Global BMI Index	18/09/23
Anteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023	12/09/23
Anteris Technologies Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23
Anteris Technologies Ltd - DurAVR Demonstrates Exceptional Results in Second Valve-in-Valve Case	15/08/23
DurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Case	14/08/23
Anteris Technologies Ltd Announces DurAVR THV Demonstrates Exceptional Results in Second Valve-in-Valve Case	14/08/23
Anteris Technologies Ltd - Montefiore Health System Enrolls Patients in the US Early Feasibility Study	10/08/23
Anteris Technologies Commences American Depository Receipt Program	09/08/23
Anteris Technologies Commences US Early Feasibility Study	09/08/23
Montefiore Enrolls Patients for US Early Feasibility Study for Anteris Technologies' DurAVR THV	09/08/23
Anteris welcomes successful DurAVR valve-in-valve procedure	01/08/23
Anteris Technologies Ltd - First Successful Implantation of DurAVR THV in a Valve-in-Valve Procedure	01/08/23
Anteris Technologies Announces First Successful Implantation of DurAVR™ THV in a Valve-in-Valve Procedure	31/07/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Anteris Technologies Ltd

Acciones

AVR

AU0000088841

Otros idiomas

Filtros